inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis.
Article Details
- CitationCopy to clipboard
Banerjee A, Dubnau E, Quemard A, Balasubramanian V, Um KS, Wilson T, Collins D, de Lisle G, Jacobs WR Jr
inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis.
Science. 1994 Jan 14;263(5144):227-30.
- PubMed ID
- 8284673 [ View in PubMed]
- Abstract
Isoniazid (isonicotinic acid hydrazide, INH) is one of the most widely used antituberculosis drugs, yet its precise target of action on Mycobacterium tuberculosis is unknown. A missense mutation within the mycobacterial inhA gene was shown to confer resistance to both INH and ethionamide (ETH) in M. smegmatis and in M. bovis. The wild-type inhA gene also conferred INH and ETH resistance when transferred on a multicopy plasmid vector to M. smegmatis and M. bovis BCG. The InhA protein shows significant sequence conservation with the Escherichia coli enzyme EnvM, and cell-free assays indicate that it may be involved in mycolic acid biosynthesis. These results suggest that InhA is likely a primary target of action for INH and ETH.
DrugBank Data that Cites this Article
- Drug Targets
Drug Target Kind Organism Pharmacological Action Actions Ethionamide Enoyl-[acyl-carrier-protein] reductase [NADH] Protein Mycobacterium tuberculosis YesInhibitorDetails - Polypeptides
Name UniProt ID Enoyl-[acyl-carrier-protein] reductase [NADH] P9WGR1 Details